Lichen International Limited (LICN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Lichen International Limited (LICN) stock price & volume — 10-year historical chart
Lichen International Limited (LICN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Lichen International Limited (LICN) competitors in Professional Advisory and Compliance Services — business model, growth, and fundamentals comparison
Lichen International Limited (LICN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Lichen International Limited (LICN) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'15 | Dec'16 | Dec'17 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 14.76M | 20.78M | 25.58M | 31.6M | 30.67M | 34.3M | 33.8M | 39.76M | 41.48M | 79.57M |
| Revenue Growth % | 59.3% | 40.78% | 23.09% | 23.54% | -2.96% | 11.83% | -1.43% | 17.61% | 4.32% | 18.69% |
| Cost of Goods Sold | 4.23M | 5.61M | 7.35M | 12.26M | 11.83M | 13.82M | 13.61M | 15.44M | 15.8M | 32.81M |
| COGS % of Revenue | 28.66% | 26.98% | 28.72% | 38.79% | 38.58% | 40.3% | 40.27% | 38.83% | 38.1% | - |
| Gross Profit | 10.53M▲ 0% | 15.17M▲ 44.1% | 18.24M▲ 20.2% | 19.34M▲ 6.1% | 18.84M▼ 2.6% | 20.48M▲ 8.7% | 20.19M▼ 1.4% | 24.32M▲ 20.4% | 25.67M▲ 5.6% | 46.76M▲ 0% |
| Gross Margin % | 71.34% | 73.02% | 71.28% | 61.21% | 61.42% | 59.7% | 59.73% | 61.17% | 61.9% | 58.77% |
| Gross Profit Growth % | 70.04% | 44.07% | 20.17% | 6.07% | -2.62% | 8.7% | -1.38% | 20.44% | 5.57% | - |
| Operating Expenses | 5.14M | 6.55M | 8.93M | 9.62M | 10.05M | 9.18M | 9.54M | 12.06M | 30.23M | 47.14M |
| OpEx % of Revenue | 34.82% | 31.5% | 34.91% | 30.42% | 32.77% | 26.76% | 28.23% | 30.34% | 72.87% | - |
| Selling, General & Admin | 4.74M | 6.15M | 8.31M | 9.62M | 10.05M | 9.18M | 9.54M | 12.06M | 30.23M | 47.15M |
| SG&A % of Revenue | 32.14% | 29.59% | 32.49% | 30.42% | 32.77% | 26.76% | 28.23% | 30.34% | 72.87% | - |
| Research & Development | 396.65K | 397.38K | 620.13K | 0 | 930K | 1.08M | 1.06M | 1.19M | 1.38M | 2.57M |
| R&D % of Revenue | 2.69% | 1.91% | 2.42% | - | 3.03% | 3.15% | 3.14% | 2.99% | 3.33% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -930K | -1.08M | -1.06M | -1.19M | -1.38M | -2M |
| Operating Income | 5.39M▲ 0% | 8.63M▲ 60.0% | 9.3M▲ 7.8% | 9.73M▲ 4.5% | 8.79M▼ 9.7% | 11.3M▲ 28.6% | 10.65M▼ 5.8% | 12.26M▲ 15.1% | -4.55M▼ 137.1% | -391K▲ 0% |
| Operating Margin % | 36.52% | 41.52% | 36.37% | 30.78% | 28.65% | 32.94% | 31.5% | 30.83% | -10.97% | -0.49% |
| Operating Income Growth % | 119.41% | 60.03% | 7.84% | 4.55% | -9.67% | 28.58% | -5.75% | 15.13% | -137.12% | - |
| EBITDA | 5.59M | 8.93M | 9.76M | 11.92M | 9.59M | 13.75M | 11.35M | 13.01M | -1.68M | 4.67M |
| EBITDA Margin % | 37.89% | 42.98% | 38.16% | 37.71% | 31.28% | 40.09% | 33.57% | 32.73% | -4.04% | 5.86% |
| EBITDA Growth % | 119.29% | 59.71% | 9.27% | 22.09% | -19.51% | 43.31% | -17.45% | 14.65% | -112.88% | -76.24% |
| D&A (Non-Cash Add-back) | 202.06K | 305.26K | 457.22K | 2.19M | 806K | 2.45M | 701K | 753K | 2.88M | 5.06M |
| EBIT | 5.42M | 8.65M | 9.36M | 9.78M | 8.79M | 11.3M | 10.65M | 12.26M | -4.55M | -391K |
| Net Interest Income | 0 | 0 | 0 | 0 | 103K | 28K | 60K | 38K | 163K | 189K |
| Interest Income | 11.61K | 17.76K | 31.52K | 49K | 103K | 28K | 60K | 38K | 163K | 189K |
| Interest Expense | 0 | 0 | 0 | 49K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 28.96K | 23.93K | 59.18K | 5K | 209K | 216K | 94K | -671K | 379K | -3.44M |
| Pretax Income | 5.42M▲ 0% | 8.65M▲ 59.6% | 9.36M▲ 8.2% | 9.73M▲ 3.9% | 9M▼ 7.6% | 11.51M▲ 28.0% | 10.74M▼ 6.7% | 11.59M▲ 7.9% | -4.17M▼ 136.0% | -3.83M▲ 0% |
| Pretax Margin % | 36.72% | 41.63% | 36.6% | 30.8% | 29.33% | 33.57% | 31.78% | 29.15% | -10.06% | -4.81% |
| Income Tax | 1.46M | 2.42M | 2.86M | 2.66M | 2.59M | 3.05M | 2.92M | 3.25M | 1.95M | 4.49M |
| Effective Tax Rate % | 26.95% | 27.97% | 30.53% | 27.36% | 28.78% | 26.51% | 27.22% | 28.05% | -46.69% | -117.2% |
| Net Income | 3.96M▲ 0% | 5.82M▲ 46.8% | 6.51M▲ 11.8% | 7.07M▲ 8.7% | 6.41M▼ 9.4% | 8.46M▲ 32.1% | 7.82M▼ 7.6% | 8.34M▲ 6.7% | -6.14M▼ 173.6% | -8.51M▲ 0% |
| Net Margin % | 26.85% | 28% | 25.43% | 22.37% | 20.89% | 24.67% | 23.13% | 20.97% | -14.8% | -10.7% |
| Net Income Growth % | 117.43% | 46.82% | 11.8% | 8.68% | -9.38% | 32.07% | -7.61% | 6.65% | -173.63% | -166.71% |
| Net Income (Continuing) | 3.96M | 6.23M | 6.51M | 7.07M | 6.41M | 8.46M | 7.82M | 8.34M | -6.12M | -8.32M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -4.62K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.38M | 0 |
| EPS (Diluted) | 0.14▲ 0% | 0.20▲ 42.9% | 0.23▲ 15.0% | 0.25▲ 8.7% | 0.22▼ 12.0% | 0.29▲ 31.8% | 69.49▲ 23862.1% | 63.96▼ 8.0% | -0.41▼ 100.6% | -30.10▲ 0% |
| EPS Growth % | 122.22% | 42.86% | 15% | 8.7% | -12% | 31.82% | 23862.07% | -7.96% | -100.64% | -6035.76% |
| EPS (Basic) | 0.14 | 0.20 | 0.23 | 0.25 | 0.22 | 0.29 | 69.49 | 63.96 | -0.41 | - |
| Diluted Shares Outstanding | 28.75M | 28.75M | 28.75M | 28.75M | 28.75M | 28.75M | 22.5M | 26.51M | 14.87M | 282.85K |
| Basic Shares Outstanding | 28.75M | 28.75M | 28.75M | 28.75M | 28.75M | 28.75M | 22.5M | 26.51M | 14.87M | 282.85K |
| Dividend Payout Ratio | - | 51.73% | - | 102.52% | 67.86% | - | - | - | - | - |
Lichen International Limited (LICN) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'15 | Dec'16 | Dec'17 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 10.7M | 12.62M | 10.84M | 7.42M | 11.65M | 23.89M | 27.27M | 40.13M | 34.01M | 28.32M |
| Cash & Short-Term Investments | 1.72M | 4.62M | 5.01M | 5.39M | 8.66M | 16.84M | 22.6M | 25.86M | 26.71M | 22.57M |
| Cash Only | 1.72M | 4.62M | 5.01M | 5.39M | 8.66M | 16.84M | 22.6M | 25.86M | 26.71M | 22.57M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 4.24M | 2.47M | 2.39M | 1.88M | 2.83M | 4.36M | 3.54M | 4.46M | 7.09M | 2.13M |
| Days Sales Outstanding | 104.94 | 43.39 | 34.06 | 21.72 | 33.72 | 46.41 | 38.28 | 40.97 | 62.43 | 19.09 |
| Inventory | 49.13K | 34.25K | 38.7K | 33K | 23K | 150K | 127K | 87K | 67K | 0 |
| Days Inventory Outstanding | 4.24 | 2.23 | 1.92 | 0.98 | 0.71 | 3.96 | 3.41 | 2.06 | 1.55 | 0.58 |
| Other Current Assets | 4.62M | 5.47M | 3.38M | 118K | 48K | 2.24M | 46K | 5.72M | 74K | 3.43M |
| Total Non-Current Assets | 779.23K | 2.11M | 11.01M | 21.37M | 21.7M | 19.05M | 19.26M | 25.41M | 45.83M | 38.88M |
| Property, Plant & Equipment | 387.77K | 1.19M | 10.26M | 15.46M | 15.77M | 14.94M | 13.5M | 14.76M | 13.75M | 7.31M |
| Fixed Asset Turnover | 38.07x | 17.53x | 2.49x | 2.04x | 1.94x | 2.30x | 2.50x | 2.69x | 3.02x | 6.36x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.45M | 4.45M |
| Intangible Assets | 0 | 0 | 0 | 5.51M | 5.59M | 3.87M | 4.52M | 6.03M | 11.05M | 9.51M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 145K | 1.33M |
| Other Non-Current Assets | 391.46K | 923.66K | 743.55K | 401K | 337K | 250K | 1.24M | 4.63M | 16.43M | 42.04M |
| Total Assets | 11.48M▲ 0% | 14.73M▲ 28.2% | 21.85M▲ 48.4% | 28.79M▲ 31.8% | 33.35M▲ 15.8% | 42.94M▲ 28.8% | 46.52M▲ 8.3% | 65.55M▲ 40.9% | 79.84M▲ 21.8% | 67.21M▲ 0% |
| Asset Turnover | 1.29x | 1.41x | 1.17x | 1.10x | 0.92x | 0.80x | 0.73x | 0.61x | 0.52x | 1.12x |
| Asset Growth % | 127.21% | 28.23% | 48.37% | 31.77% | 15.83% | 28.77% | 8.34% | 40.88% | 21.81% | 84.46% |
| Total Current Liabilities | 3.09M | 3.82M | 3.28M | 5.07M | 5.71M | 6.11M | 5.23M | 4.09M | 4.27M | 2.78M |
| Accounts Payable | 42.35K | 108.35K | 46.38K | 85K | 95K | 123K | 161K | 61K | 55K | 0 |
| Days Payables Outstanding | 3.65 | 7.05 | 2.3 | 2.53 | 2.93 | 3.25 | 4.32 | 1.44 | 1.27 | 0.54 |
| Short-Term Debt | 0 | 0 | 0 | 315K | 337K | 345K | 88K | 0 | 0 | 78K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 1.18M | 1.1M | 1.27M | 1.15M | 1.03M | 696K | 2.58M |
| Other Current Liabilities | 3.05M | 3.72M | 3.23M | 3.41M | 3.57M | 3.77M | 3.75M | 1.68M | 150K | 412K |
| Current Ratio | 3.46x | 3.30x | 3.31x | 1.47x | 2.04x | 3.91x | 5.21x | 9.81x | 7.96x | 7.96x |
| Quick Ratio | 3.45x | 3.29x | 3.30x | 1.46x | 2.04x | 3.88x | 5.19x | 9.79x | 7.95x | 7.95x |
| Cash Conversion Cycle | 105.53 | 38.57 | 33.68 | 20.18 | 31.5 | 47.13 | 37.36 | 41.59 | 62.7 | 19.12 |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 1.74M | 184K | 34K | 5K | 176K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 184K | 34K | 5K | 223K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.09M | 3.82M | 3.28M | 5.07M | 5.71M | 6.11M | 5.42M | 4.13M | 4.28M | 2.96M |
| Total Debt | 0 | 0 | 0 | 315K | 337K | 345K | 272K | 129K | 61K | 357K |
| Net Debt | -1.72M | -4.62M | -5.01M | -5.08M | -8.33M | -16.5M | -22.33M | -25.73M | -26.65M | -22.22M |
| Debt / Equity | - | - | - | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | 0.03x | 0.04x | 0.03x | 0.02x | 0.01x | - | 0.08x |
| Net Debt / EBITDA | -0.31x | -0.52x | -0.51x | -0.43x | -0.87x | -1.20x | -1.97x | -1.98x | - | -4.76x |
| Interest Coverage | - | - | - | 199.63x | - | - | - | - | - | - |
| Total Equity | 8.39M▲ 0% | 10.9M▲ 29.9% | 18.57M▲ 70.4% | 23.73M▲ 27.8% | 27.64M▲ 16.5% | 36.83M▲ 33.2% | 41.11M▲ 11.6% | 61.42M▲ 49.4% | 75.56M▲ 23.0% | 64.25M▲ 0% |
| Equity Growth % | 124.3% | 29.88% | 70.37% | 27.75% | 16.51% | 33.24% | 11.61% | 49.41% | 23.03% | 95.49% |
| Book Value per Share | 0.29 | 0.38 | 0.65 | 0.83 | 0.96 | 1.28 | 1.83 | 2.32 | 5.08 | 227.16 |
| Total Shareholders' Equity | 8.4M | 10.9M | 18.57M | 23.73M | 27.64M | 36.83M | 41.11M | 61.42M | 73.18M | 64.25M |
| Common Stock | 0 | 144 | 154 | 1K | 1K | 1K | 1K | 1K | 4K | 6K |
| Retained Earnings | 6.25M | 7.42M | 14.67M | 22.49M | 24.55M | 33.01M | 40.83M | 48.22M | 42.08M | 34.46M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 2.15M | 2.14M | 2.47M | -256K | 1.6M | 2.33M | -1.21M | -1.7M | -2.26M | -3.84M |
| Minority Interest | -4.62K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.38M | 0 |
Lichen International Limited (LICN) cash flow — operating, investing & free cash flow history
| Line item | Dec'15 | Dec'16 | Dec'17 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 3.72M | 8.8M | 6.36M | 13.57M | 8.35M | 7.3M | 10.77M | 557K | -5.57M | -5.57M |
| Operating CF Margin % | 25.18% | 42.33% | 24.88% | 42.94% | 27.23% | 21.3% | 31.85% | 1.4% | -13.43% | - |
| Operating CF Growth % | 195.04% | 136.71% | -27.66% | 113.21% | -38.46% | -12.53% | 47.4% | -94.83% | -1100.36% | 1376.5% |
| Net Income | 3.96M | 5.82M | 6.51M | 7.07M | 6.41M | 8.46M | 7.82M | 8.34M | -6.12M | -8.51M |
| Depreciation & Amortization | 202.06K | 305.26K | 457.22K | 2.19M | 2.16M | 2.45M | 2.68M | 2.92M | 2.88M | 5.28M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.41M | 1.01M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.31M | 526.98K | -604.74K | -5K | 87K | 63K | 50K | 72K | 109K | 6.44M |
| Working Capital Changes | -899.74K | 1.38M | 460.33K | 4.31M | -304K | -3.67M | 217K | -10.78M | -5.85M | -10.96M |
| Change in Receivables | -2.88M | 1.27M | 136.43K | -2.36M | -465K | -1.45M | 66K | -982K | 642K | 1.07M |
| Change in Inventory | -14.32K | 12.19K | -2.07K | 3K | 11K | -126K | 11K | 38K | 19K | 130K |
| Change in Payables | 1.44M | 100.4K | 325.97K | 64K | 4K | 25K | 51K | -98K | -4K | 15K |
| Cash from Investing | -4.9M | -2.96M | -6.53M | -10.83M | -1.16M | 561K | -2.84M | -9.87M | -9.89M | -12.51M |
| Capital Expenditures | -122.99K | -1.76M | -4.46M | -10.83M | -1.16M | -28K | -2.84M | -5.27M | -36K | -2.33M |
| CapEx % of Revenue | 0.83% | 8.45% | 17.42% | 34.26% | 3.78% | 0.08% | 8.41% | 13.25% | 0.09% | - |
| Acquisitions | 0 | 4.52K | 0 | 0 | 0 | 589K | 0 | 0 | -3.96M | -2.41M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -4.77M | -1.2M | -2.07M | 0 | 0 | 0 | 0 | -4.6M | -5.9M | -7.77M |
| Cash from Financing | 2.3M | -2.66M | 244K | -8.99M | -4.35M | 0 | -327K | 14.1M | 13.09M | 18.18M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | -327K | 0 | 0 | 0 |
| Equity Issued (Net) | 1.02M | 0 | 0 | 0 | 0 | 0 | 0 | 14.1M | 12.22M | 18.1M |
| Dividends Paid | 0 | -3.01M | 0 | -7.25M | -4.35M | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.28M | 346.5K | 244K | -1.74M | 0 | 0 | 0 | 0 | 866K | 78K |
| Net Change in Cash | 1.12M▲ 0% | 2.9M▲ 158.9% | 390.18K▼ 86.6% | 376.18K▼ 3.6% | 3.27M▲ 770.6% | 8.18M▲ 149.8% | 5.75M▼ 29.7% | 3.26M▼ 43.4% | 856K▼ 73.7% | 26.09M▲ 0% |
| Free Cash Flow | 3.59M▲ 0% | 7.04M▲ 95.9% | 1.91M▼ 72.9% | 2.74M▲ 43.6% | 7.19M▲ 162.3% | 7.28M▲ 1.2% | 7.92M▲ 8.9% | -2.65M▼ 133.4% | -11.51M▼ 334.6% | -9.07M▲ 0% |
| FCF Margin % | 24.34% | 33.88% | 7.46% | 8.67% | 23.45% | 21.22% | 23.44% | -6.66% | -27.74% | -11.4% |
| FCF Growth % | 815.02% | 95.94% | -72.9% | 43.62% | 162.31% | 1.2% | 8.91% | -133.4% | -334.64% | -231.51% |
| FCF per Share | 0.12 | 0.24 | 0.07 | 0.10 | 0.25 | 0.25 | 0.35 | -0.10 | -0.77 | -0.77 |
| FCF Conversion (FCF/Net Income) | 0.94x | 1.51x | 0.98x | 1.92x | 1.30x | 0.86x | 1.38x | 0.07x | 0.91x | 1.07x |
| Interest Paid | 0 | 0 | 0 | 0 | 15K | 15K | 1K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 2.31M | 2.98M | 2.96M | 2.63M | 2.41M | 0 |
Lichen International Limited (LICN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 65.32% | 60.32% | 44.15% | 33.43% | 24.95% | 26.25% | 20.06% | 16.26% | -8.96% | -12.57% |
| Return on Invested Capital (ROIC) | 82.95% | 99.95% | 70.37% | 45.31% | 34.72% | 42.74% | 40.83% | 33.76% | -8.07% | -8.07% |
| Gross Margin | 71.34% | 73.02% | 71.28% | 61.21% | 61.42% | 59.7% | 59.73% | 61.17% | 61.9% | 58.77% |
| Net Margin | 26.85% | 28% | 25.43% | 22.37% | 20.89% | 24.67% | 23.13% | 20.97% | -14.8% | -10.7% |
| Debt / Equity | - | - | - | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| Interest Coverage | - | - | - | 199.63x | - | - | - | - | - | - |
| FCF Conversion | 0.94x | 1.51x | 0.98x | 1.92x | 1.30x | 0.86x | 1.38x | 0.07x | 0.91x | 1.07x |
| Revenue Growth | 59.3% | 40.78% | 23.09% | 23.54% | -2.96% | 11.83% | -1.43% | 17.61% | 4.32% | 18.69% |
Lichen International Limited (LICN) stock FAQ — growth, dividends, profitability & financials explained
Lichen International Limited (LICN) reported $79.6M in revenue for fiscal year 2024. This represents a 759% increase from $9.3M in 2014.
Lichen International Limited (LICN) grew revenue by 4.3% over the past year. Growth has been modest.
Lichen International Limited (LICN) reported a net loss of $8.5M for fiscal year 2024.
Lichen International Limited (LICN) has a return on equity (ROE) of -9.0%. Negative ROE indicates the company is unprofitable.
Lichen International Limited (LICN) had negative free cash flow of $9.1M in fiscal year 2024, likely due to heavy capital investments.
Lichen International Limited (LICN) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates